Drug intelligence / Profile preview

ZeniCOL

Development stage
Unknown
Lead developer
Focus Health Group
Modality
Recombinant Proteins and Enzymes
Administration
Topical
01

Overview

ZeniCOL is a topical wound care product developed by Focus Health Group, consisting of a 100% native, non-hydrolyzed bovine collagen dressing. It is indicated for the management of various wound types, including dry to moist wounds, burns, sores, blisters, scrapes, and chronic ulcers (such as pressure, venous, and diabetic ulcers). The dressing acts as a biological scaffold that promotes angiogenesis and the formation of granulation tissue while stimulating collagen deposition. Furthermore, it helps to modulate the wound environment by decreasing the levels of matrix metalloproteinases (MMPs), which can otherwise stall the healing process in chronic wounds. ZeniCOL is available in multiple formats, including pads and granules for deep or tunneling wounds. A silver-containing variant, ZeniCOL Ag, is also available for wounds requiring antimicrobial protection.

Brand names
ZeniCOLZeniCOL Ag
02

Targets

MMP8 (Neutrophil collagenase)

Beyond the preview

Go deeper on ZeniCOL.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ZeniCOL.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call